The role of adenosinergic pathway in human autoimmune diseases - Wikidata - awgldk - TriplyDB

The role of adenosinergic pathway in human autoimmune diseases

The role of adenosinergic pathway in human autoimmune diseases

http://www.wikidata.org/entity/Q28069199

about

New Insights into the Immunobiology of Mononuclear Phagocytic Cells and Their Relevance to the Pathogenesis of Cardiovascular Diseases.Ectonucleotidase-Mediated Suppression of Lupus Autoimmunity and Vascular Dysfunction.

P2860

Q49531175-9BC1867C-875B-4B5A-B504-ED2D3F170363 Q55475388-987FAA84-8E26-474E-9262-A04C8B95C9B6

P2860

The role of adenosinergic pathway in human autoimmune diseases

http://www.wikidata.org/entity/Q28069199

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

The role of adenosinergic pathway in human autoimmune diseases

@ast

The role of adenosinergic pathway in human autoimmune diseases

@en

The role of adenosinergic pathway in human autoimmune diseases

@nl

type

label

The role of adenosinergic pathway in human autoimmune diseases

@ast

The role of adenosinergic pathway in human autoimmune diseases

@en

The role of adenosinergic pathway in human autoimmune diseases

@nl

prefLabel

The role of adenosinergic pathway in human autoimmune diseases

@ast

The role of adenosinergic pathway in human autoimmune diseases

@en

The role of adenosinergic pathway in human autoimmune diseases

@nl

P1433

Q28069199-8CBAD560-7420-4104-B4FF-CF74904A843B

P1476

Q28069199-079823F0-3CC3-421E-86E5-1D609CDC8C2F

P2093

Q28069199-40FBCE8F-11D8-4B47-B7E6-9C7290C893FF

Q28069199-78ED51FC-F978-404C-B4ED-8000183D48C8

Q28069199-9F5498CD-6B32-4A8B-82E3-B365B3F1A109

P275

Q28069199-7F692E21-E91A-4D2D-A8C5-2218CF8FC028

P2860

Q28069199-02C4F557-52E4-4B2E-AC0B-24528E134AAB

Q28069199-04B01C4B-5DD0-4174-9613-E17753BD7B1D

Q28069199-051BAC6B-2700-4CFA-92E7-34D0B8D4B482

Q28069199-1AA8E18D-DC6B-4252-9CC0-1664F7B99447

Q28069199-2474F618-7E44-4F7C-B4DE-88AB21FD6982

Q28069199-31B286CD-52D1-4F6B-9BF4-75EBC4BBEB6C

Q28069199-35AA73FD-95F4-4203-A5DE-2676702620F8

Q28069199-39C43353-3BB1-4BD7-AA0E-B65E1B10A94D

Q28069199-3C9E1037-047B-451B-9B3F-7FF978AF3623

Q28069199-40D308F4-464C-49A1-A34E-C5342A74D6EE

P2888

Q28069199-AF0E0943-4497-41A6-93A9-25C174880A80

P304

Q28069199-C0CFF957-9A6A-4254-BC74-6D42DFFC4156

P31

Q28069199-36B8DEB8-84CC-445C-B5D1-62BB1CEE1679

Q28069199-424846F1-08F6-4DD2-B1B7-78C1368F809F

P3181

Q28069199-AE8642ED-5B5B-437C-8D81-370A7D15E691

P356

Q28069199-1740D2FE-1ADC-4A0F-9CDC-23DCEB5DECF4

P407

Q28069199-80CE2B27-C7D6-49A6-885D-B58D3B1E2FE7

P433

Q28069199-788026C3-B3AA-4A23-AFB8-9E81BB2AD164

P478

Q28069199-0FC4FF71-A3A8-45A1-BEF7-47D824336455

P5008

Q28069199-DD616932-342E-456E-9582-6458A9CA4645

P577

Q28069199-1B1A3E9E-D078-4B06-B14D-48417C85760E

Q28069199-22A67A0A-D0E6-4C24-AA9E-C0C7F479F936

P6179

Q28069199-99E7E98A-53D2-4F4A-B586-DAE7E90DF830

P698

Q28069199-E0B07436-5525-4782-B78C-8DEF8D62936B

P921

Q28069199-7CD5114B-4578-4A4E-B704-1EB440F7D4E2

Q28069199-C43D5C77-E37B-4FF7-B8A9-EB87305D3CA0

P932

Q28069199-CF333D93-1537-4691-B9E0-1097331A8848

P3181

P356

S12026-016-8870-2

P1433

Immunologic Research

P1476

The role of adenosinergic pathway in human autoimmune diseases

@en

P2093

Hui-zhong Zhang

http://www.w3.org/2001/XMLSchema#string

Ke Dong

http://www.w3.org/2001/XMLSchema#string

Zhao-wei Gao

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.

Clearance of rapid adenosine release is regulated by nucleoside transporters and metabolism.

Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.

The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus.

Adenosine: an endogenous regulator of innate immunity.

Clinical associations of serum interleukin-17 in systemic lupus erythematosus.

Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus.

Rat models as tool to develop new immunotherapies.

Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.

The role of interleukin-17 in the pathogenesis of rheumatoid arthritis.

P2888

s12026-016-8870-2

P304

1133-1141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3356499

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S12026-016-8870-2

http://www.w3.org/2001/XMLSchema#string

P407

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

64

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1011981096

http://www.w3.org/2001/XMLSchema#string

P698

27665459

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

autoimmune disease

P932

5126201

http://www.w3.org/2001/XMLSchema#string